跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-SOTALOL TABLET 160 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-SOTALOL TABLET 160 mg
Approved
THERAPEUTIC
APO-SOTALOL TABLET 160 mg
APOTEX INC
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 1997
Approval ID
a1916513b9e7d146
Company
APOTEX INC
Type
Therapeutic
Approval Details
Approval Id
a1916513b9e7d146
Drug Name
APO-SOTALOL TABLET 160 mg
Product Name
APO-SOTALOL TABLET 160 mg
Approval Number
SIN09139P
Approval Date
1997-01-13
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C07AA07
Atc Item Name
sotalol
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
SOTALOL HCl
160 mg
SOTALOL HCL
160 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 1997
Approval ID
a1916513b9e7d146
Type
Therapeutic
Back to HSA Approvals